argenx (ARGX.US) — market event timeline
nashnova tracks 1 market event mentioning argenx (ARGX.US) as of 2026-08-31, each with a dated one-line analysis of how the event relates to the asset.
- Eli Lilly to Acquire Merida Biosciences for Up to $2.875 Billion, Expanding into Autoimmune Antibody Degradation Therapy
Argenx's FcRn inhibitors belong to the same antibody clearance space; Lilly's high-premium acquisition validates this therapeutic approach and serves as a valuation benchmark.
For research and information only — not investment advice.